| Number | Percentage (100%) |
---|---|---|
Age | ||
  < 1 year | 40 | 52 |
 1–2 years | 14 | 18 |
  > 2 years | 23 | 30 |
Gender | ||
 Male | 38 | 49 |
 Female | 39 | 51 |
Swelling | ||
 Yes | 55 | 71 |
 No | 22 | 29 |
Pain | ||
 Yes | 30 | 39 |
 No | 47 | 61 |
Disfigurement | ||
 Yes | 42 | 55 |
 No | 35 | 45 |
Discoloration | ||
 Yes | 41 | 53 |
 No | 36 | 47 |
Bleeding | ||
 Yes | 32 | 42 |
 No | 45 | 58 |
Limited motion | ||
 Yes | 10 | 13 |
 No | 67 | 87 |
Morphological subtypes | ||
 Macrocystic LMs | 31 | 40 |
 Microcystic LMs | 21 | 27 |
 Mixed LMs (macrocystic and microcystic) | 25 | 33 |
 Anatomical location | ||
 Head and neck | 35 | 45 |
 Thorax | 12 | 16 |
 Abdomen and pelvis | 10 | 13 |
 Upper extremity | 8 | 10 |
 Lower extremity | 9 | 12 |
 Abdomen/pelvis/lower extremity | 3 | 4 |
Extent | ||
 Focal | 62 | 81 |
 Diffuse | 15 | 19 |
 | Mean | Range |
---|---|---|
Age (years) | 3.3 | 1 day—18 years |
Treatment sessions (No.) | 3.1 | 1–6 |
Follow-up period (months) | 18 | 6–30 |